Robert Kitchen | Head of Systems Biology and Target Discovery
Novo Nordisk

Robert Kitchen, Ph.D. leads a global computational biology team at Novo Nordisk.  The department focuses on applying systems biology and machine learning to identify drug target candidates from high-throughput in-vitro functional screening and unveiling endotypes of cardiometabolic diseases.  Prior to joining Novo Nordisk’s research centre in Oxford, UK, Robert was a Principal Investigator in the cardiology research faculty at the Massachusetts General Hospital and Harvard Medical School, Boston, USA.  There, his laboratory specialised in applying machine learning methods to model neurological and cardiovascular disorders and has substantial experience in working with transcriptomics and with multi-omics data integration.  Prior to his academic appointment, he led biomarker development and companion-diagnostics programs at Exosome Diagnostics (now part of Bio-Techne). Robert holds a PhD from the University of Edinburgh, UK, and undertook his post-doctoral training in the Gerstein and Nairn labs at Yale University, USA, focussing on systems biology, functional genomics, and molecular psychiatry.